+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Psychedelic Drug"

Psychedelic Drugs Global Market Report 2024 - Product Thumbnail Image

Psychedelic Drugs Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
Global Psychedelic Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Psychedelic Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Major Depressive Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Binge-Eating Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Binge-Eating Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Psychedelic Drugs: Global Market Outlook - Product Thumbnail Image

Psychedelic Drugs: Global Market Outlook

  • Report
  • April 2023
  • 35 Pages
  • Global
From
From
From
From
Loading Indicator

The Psychedelic Drug market is a rapidly growing sector of the Mental Disorders Drugs industry. Psychedelic drugs are substances that produce altered states of consciousness, often with spiritual or therapeutic effects. These drugs are being studied for their potential to treat a variety of mental health conditions, including depression, anxiety, PTSD, and addiction. Psychedelic drugs are being studied in clinical trials and are being used in a variety of therapeutic settings, including psychotherapy, meditation, and yoga. The potential of these drugs to treat mental health conditions has led to a surge in interest in the field, with many companies researching and developing new psychedelic drugs. Companies in the Psychedelic Drug market include Compass Pathways, Mind Medicine, ATAI Life Sciences, Field Trip Health, and Eleusis Benefit Corporation. These companies are researching and developing new psychedelic drugs, as well as providing therapeutic services and conducting clinical trials. Show Less Read more